4.3 Article

Exclusion of EGFR, HRAS, DSP, JUP, CTNNB1, PLEC1, and EPPK1 as Functional Candidate Genes in 7 Families With Syndromic Diarrhoea

Journal

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MPG.0b013e3181846aab

Keywords

Catenins; Intercellular junctions; Plakins; Syndromic diarrhoea; Tricho-hepato-enteric syndrome

Funding

  1. Association Pour le Developpement des Recherches Biologiques et Medicales au Centre Hospitalier Regional de Marseille

Ask authors/readers for more resources

Syndromic diarrhoea (SD) is a rare disease associating intractable diarrhoea and hair abnormalities. In an attempt to identify the gene causative for SD, we studied several functional candidate genes, based on their implication in overlapping phenotypes in mice (EGFR) or in humans (HRAS, JUP, DSP EPPK1, PLEC1, and CTNNB1) in 8 patients affected by SD. Except for EGFR and HRAS, all selected genes encode for cell adhesion proteins. Using direct sequencing or linkage analysis, we excluded all of the candidate genes as the disease-causing gene in our group of patients; however, the hypothesis of intercellular junctions defect in SD remains seductive. JPGN 48:501-503, 2009.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pharmacology & Pharmacy

Pharmacokinetics of oral vinorelbine in French children with recurrent or progressive primary low-grade glioma

Mourad Hamimed, Florence Gattacceca, Nicolas Andre, Emmanuelle Tresch-Bruneel, Alicia Probst, Pascal Chastagner, Anne Pagnier, Emilie De Carli, Natacha Entz-Werle, Jacques Grill, Isabelle Aerts, Didier Frappaz, Anne-Isabelle Bertozzi-Salamon, Caroline Solas, Pierre Leblond

Summary: The PK profile of orally administered vinorelbine was assessed in children with recurrent/progressive low-grade glioma. Higher doses may be necessary for children with LGG, and body surface area has a significant impact on vinorelbine systemic exposure. These findings will contribute to further research on vinorelbine concentration-response relationships in pediatric patients.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Letter Oncology

Six-month BNT162b2 vaccine efficacy in adolescents and young adults with cancer

Caroline Donze, Laetitia Ninove, Xavier de Lamballerie, Paul Saultier, Nicolas Andre

PEDIATRIC BLOOD & CANCER (2022)

Review Oncology

Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial

Simon Bailey, Nicolas Andre, Lorenza Gandola, Maura Massimino, Stefan Rutkowski, Steven C. Clifford

Summary: Patients with medulloblastoma are treated based on risk stratification, with the first international biomarker-driven, randomised clinical trial for high-risk medulloblastoma currently being conducted in Europe. The trial aims to recruit over 800 patients and assess the relative efficacies of different established regimens.

CANCERS (2022)

Article Oncology

The role of irinotecan-bevacizumab as rescue regimen in children with low-grade gliomas: a retrospective nationwide study in 72 patients

Charles de Marcellus, Arnault Tauziede-Espariat, Aurelie Cuinet, Claudia Pasqualini, Matthieu P. Robert, Kevin Beccaria, Stephanie Puget, Nathalie Boddaert, Dominique Figarella-Branger, Emilie De Carli, Franck Bourdeaut, Pierre Leblond, Fanny Fouyssac, Nicolas Andre, Anne Bertozzi, Thibaut Butel, Christelle Dufour, Dominique Valteau-Couanet, Pascale Varlet, Jacques Grill

Summary: This retrospective analysis evaluated the efficacy and toxicity of irinotecan-bevacizumab combination therapy in children with low-grade glioma (LGG). The results showed that the treatment was effective in stabilizing the disease in 96% of patients, but the response was not sustainable, especially in younger children. The most frequent toxicities were related to bevacizumab and irinotecan.

JOURNAL OF NEURO-ONCOLOGY (2022)

Article Pediatrics

Estimating the prevalence of congenital disaccharidase deficiencies using allele frequencies from gnomAD

C. de Leusse, C. Roman, B. Roquelaure, A. Fabre

Summary: Among the known congenital disaccharidase deficiencies, the prevalence is relatively high for congenital lactase deficiency and congenital sucrase-isomaltase deficiency, while the prevalence is low for congenital trehalase deficiency.

ARCHIVES DE PEDIATRIE (2022)

Article Pediatrics

Individual and Family Determinants for Quality of Life in Parents of Children with Inborn Errors of Metabolism Requiring a Restricted Diet: A Multilevel Analysis Approach

Abdoulaye Ouattara, Noemie Resseguier, Aline Cano, Pascale De Lonlay, Jean-Baptiste Arnoux, Anais Brassier, Manuel Schiff, Samia Pichard, Alexandre Fabre, Celia Hoebeke, Nathalie Guffon, Alain Fouilhoux, Pierre Broue, Guy Touati, Dries Dobbelaere, Karine Mention, Francois Labarthe, Marine Tardieu, Loic De Parscau, Francois Feillet, Chrystele Bonnemains, Alice Kuster, Philippe Labrune, Magalie Barth, Lena Damaj, Delphine Lamireau, Julie Berbis, Pascal Auquier, Brigitte Chabrol

Summary: The objective of this study was to compare the quality of life (QoL) of parents of children with inborn errors of metabolism (IEMs) requiring a restricted diet with the French population norms and investigate the determinants of parental QoL. The results showed that compared to the general population, parents of children with IEMs requiring a restricted diet reported lower QoL in physical and social relationship domains but higher QoL in the psychological domain. Factors such as parent-related characteristics and family-related factors were found to be associated with poorer parental QoL in the multivariate analysis.

JOURNAL OF PEDIATRICS (2023)

Article Medicine, General & Internal

When LUCA met gnomAD: genetic constraints on universal genes in humans

Alexandre Fabre, Julien Mancini

Summary: This study compared the constraint metrics and associations with Mendelian diseases between the LUCA gene group and a random gene group. The results showed differences in constraint and Mendelian disease associations between the two groups.

INTRACTABLE & RARE DISEASES RESEARCH (2022)

Review Medicine, General & Internal

Smooth muscle motility disorder phenotypes: A systematic review of cases associated with seven pathogenic genes (ACTG2, MYH11, FLNA, MYLK, RAD21, MYL9 and LMOD1)

Ninon Fournier, Alexandre Fabre

Summary: This study systematically reviewed the genes associated with smooth muscle disorders affecting the intestine and the bladder. The most commonly involved genes were ACTG2, MYH11, and FLNA, and the clinical phenotypes of the patients ranged from isolated chronic intestinal pseudo-obstruction to isolated megacystis or combined CIPO and megacystis.

INTRACTABLE & RARE DISEASES RESEARCH (2022)

Article Biochemistry & Molecular Biology

Proposed mechanism for the selection of lactase persistence in childhood

Alexandre Fabre, Anne Fabre, Celine Bon, Paul Guerry, Laure Segurel

Summary: Lactase persistence is a strongly selected phenotype in humans, encoded by multiple genetic variants. The underlying mechanism is unclear as adults, including lactase non-persistence individuals, can tolerate dairy products. Cultural adaptations, such as fermentation and transformation, in ancient societies may have provided energy to both lactase persistence and non-persistence individuals without any cost.

BIOESSAYS (2023)

Article Oncology

Mammary-analog secretory carcinoma in children: Surgery or TRK inhibitors first?

Eric Moreddu, Nicolas Andre, Romain Appay

Summary: We report two cases of pediatric mammary-analog secretory carcinoma (MASC) in which the diagnosis was challenging, but achieved by identifying the ETV6::NTRK3 fusion transcript. Both patients, a male operated on at age 8 and a female operated on at 12, are in remission 2 years after surgery. Considering the successful results of TRK inhibitor treatments in adult MASC and pediatric tumors expressing an ETV6::NTRK3 fusion, they should probably be recommended as the first-line treatment in cases with potential serious sequelae or metastatic disease that require surgery.

PEDIATRIC BLOOD & CANCER (2023)

Article Medicine, General & Internal

Retrospective National Real Life Experience of the SFCE with the Metronomic MEMMAT and MEMMAT-like Protocol

Camille Winnicki, Pierre Leblond, Franck Bourdeaut, Anne Pagnier, Gilles Paluenzela, Pascal Chastagner, Gwenaelle Duhil-De Benaze, Victoria Min, Helene Sudour-Bonnange, Catherine Piette, Natacha Entz-Werle, Sylvie Chabaud, Nicolas Andre

Summary: This study retrospectively analyzed pediatric patients with relapsed high-risk brain tumors treated with the METMAT or METMAT-like regimen. It found that this treatment approach can lead to sustained control of the tumors, with the best outcomes observed at first relapse.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Oncology

Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX)

Pierre Leblond, Emmanuelle Tresch-Bruneel, Alicia Probst, Nadege Neant, Caroline Solas, Arthur Sterin, Thomas Boulanger, Isabelle Aerts, Cecile Faure-Conter, Anne-Isabelle Bertozzi, Pascal Chastagner, Natacha Entz-Werle, Emilie De Carli, Marie-Cecile Le Deley, Gauthier Bouche, Nicolas Andre

Summary: This study tested the repurposing of two non-anticancer drugs to provide less toxic therapeutic options for children with gliomas. The recommended phase II dose of fluvastatin in combination with celecoxib for children with gliomas is 6mg/kg/day, with a fixed daily dose of celecoxib depending on weight. This combination may be explored as a maintenance treatment in low-grade glioma patients to delay tumor recurrence.

CANCERS (2023)

Article Immunology

BNT162b2 COVID-19 Vaccines in Children, Adolescents and Young Adults with Cancer-A 1-Year Follow-Up

Caroline Donze, Victoria Min, Laetitia Ninove, Xavier de Lamballerie, Gabriel Revon Riviere, Arnauld Verschuur, Paul Saultier, Nicolas Andre

Summary: This study evaluated the adverse effects and immunological response associated with BNT162B2 vaccination in children and young adults with cancer. The results showed that most patients had an increase in antibody levels and the vaccine was effective in neutralizing the SARS-CoV-2 virus. In addition, COVID-19 infections after vaccination were mild in all cases.

VACCINES (2023)

Letter Biochemistry & Molecular Biology

AcSé-ESMART, a European precision cancer medicine proof-of-concept platform trial

Birgit Geoerger, Xavier Paoletti, Francisco Bautista, Susanne A. Gatz, Lynley V. Marshall, Nicolas Andre, Pablo Berlanga, Stephane Ducassou, Claudia Pasqualini, Michela Casanova, C. Michel Zwaan, Karsten Nysom, Jonathan Rubino, Delphine Vuillier-Le Goff, Baptiste Archambaud, Samuel Abbou, Gudrun Schleiermacher, Christelle Dufour, Patricia Blanc, Natalie Hoog-Labouret, Agnes Buzyn, Gilles Vassal

NATURE MEDICINE (2023)

No Data Available